Business and Finance

Bone Therapeutics subsidiary becomes part of Catalent's cell and gene therapy unit

Granted purchase rights to Adents' assets in likely benefit for supply-chain transparency efforts

Deal will boost company's pharmaceutical commercialization influence

Healthcare marketing giant and DTP online pharmacy join forces

Company's ShipTrack acquisition strengthens logistics involvement

Teams with Symphony Health and Compile on claims and formulary and physician data support

Five reasons why the island can serve as key cog in the national medical supply chain

Finding new efficiencies, managing revenue and changing the dialogue on drug pricing

The high-speed machines will support biologic and vaccine programs at locations in US and Italy

The company will undertake the manufacturing of clinical material for Bone Therapeutics’ drug, ALLOB

Company claims masks last 300+ hours and provide 98 percent efficiency against Covid-19

The goal is to address logistical challenges through planning, site selection and design services

The services leverage technology to speed planning, budgeting and outsourcing

Merger agreement, approved by both boards, is expected to close before end of year

It marks the first time that two accrediting organizations with deeming authority from CMS have merged

With more than 1,400 employees, company focuses on development through to commercialization

Pharma, shipping, logistics and other companies shouldn’t wait for government guidance

The rise of the patient voice and increased acceptance of remote engagement are sparking a culture change across the supply chain

The deal with unnamed large pharmaceutical company reportedly won’t include vaccine transport

Service provides finance and market access teams a consistent way to visualize, extract and integrate data into existing workflows

Agreement delivers quartz vials in secondary packaging to streamline fill-finish operations for early phase drug development

Move expands security offerings for pharma and other industries

Company distributes in Africa and Central America regions

But volume and price dynamics remain volatile and uncertainty remains

New facility boosts manufacturing services for biologic projects